For fiscal 2022, Cochlear Limited's the underlying net profit guidance range has been maintained at AUD 265 - AUD 285 million, a 13% - 22% increase on underlying net profit for fiscal 2021. Guidance now incorporates cloud computing expenses and anticipates continuing COVID impacts for the balance of the year. The company expects the net profit margin (inclusive of cloud costs) to remain a little below longer term target of 18% for fiscal 2022 and fiscal 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
322 AUD | 0.00% | -2.97% | +7.82% |
05-21 | Cochlear Completes Acquisition of Oticon Medical's Cochlear Implant Business | MT |
05-21 | Cochlear Limited acquired Oticon Medical A/s from Demant A/S. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.82% | 13.79B | |
-11.50% | 20.97B | |
+8.35% | 19.01B | |
+11.42% | 10.45B | |
-15.46% | 2.16B | |
+3.83% | 1.79B | |
+21.84% | 1.5B | |
+13.72% | 616M | |
0.00% | 411M | |
+88.70% | 218M |
- Stock Market
- Equities
- COH Stock
- News Cochlear Limited
- Cochlear Limited Provides Earnings Guidance for Fiscal 2022